sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> chemotherapy induced nausea and vomiting drugs market

report

Chemotherapy-Induced Nausea and Vomiting Drugs Market, By Therapy (Serotonin Receptor Antagonists, NK1 Receptor Antagonists), Drug (Existing Drugs, Pipeline Drugs) – Global Revenue, Trends, Growth, Share, Size and Forecast To 2022

HC269 March 2017 100+ FREE 10% CUSTOMIZATION

Nausea and Vomiting are the most common side-effects associated with the cancer treatment. Most chemotherapy agents used in cancer treatments causes some degree of nausea and vomiting. The goal of the Chemotherapy-induced Nausea and Vomiting (CINV) Drugs and other Cancer Supportive Care Products is to improve the quality of patient’s life, by preventing or treating the associated conditions and symptoms. The market can be segmented into Serotonin receptor antagonist and NK1 receptor antagonist. Key players in the market are focusing on broadening their product portfolio by means of acquisitions and collaboration.   

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Chemotherapy-Induced Nausea and Vomiting Drugs Market. The scope of this report covers the Chemotherapy-Induced Nausea and Vomiting Drugs Market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The key reasons driving the growth of the Chemotherapy-induced Nausea and Vomiting Drugs market includes increasing prevalence of cancer diseases and new product development and innovations.
  • Demand from developing nations is one of the key growth opportunity drivers for this market.
  • However, factors like high cost associated with new drug development may hamper the growth of the Chemotherapy-induced Nausea and Vomiting Drugs Market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s chemotherapy-induced nausea and vomiting drugs market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the chemotherapy-induced nausea and vomiting drugs market by the following segments:

  • Chemotherapy-Induced Nausea And Vomiting Drugs Market, by Therapy
    • Serotonin Receptor Antagonists
    • NK1 Receptor Antagonists
  • Chemotherapy-Induced Nausea And Vomiting Drugs Market, by Drug
    • Existing Drugs
      • Akynzeo (Netupitant-Palonosetron FDC)
      • Aloxi (Palonosetron)
      • Emend (Aprepitant)
      • Kytril Generic (Granisetron)
      • Zofran Generic (Ondansetron)
    • Pipeline Drugs
      • SUSTOL (Granisetron Injection extended release)
      • Rolapitant

KEY MARKET PLAYERS

Key players in the chemotherapy-induced nausea and vomiting drugs market include:

  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Tesaro, Inc.
  • Helsinn Group
  • F. Hoffmann-La Roche Ltd.
  • Heron Therapeutics, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Acacia Pharma
  • Sun Pharmaceutical Industry Ltd.
  • Otsuka Holdings Co., Ltd.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Diagnostic Imaging Market, by Technologies (MRI, CT, Ultrasound, X-ray), Applications (Cancer, Cardiovascular, Neurology, Orthopedic, Abdominal, Gynaecology), End-users (Hospital, Research Laboratory, Diagnostic Laboratory) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Product Roadmap
  5. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET, BY THERAPY
    1. Segment Share
    2. Therapy
      1. Serotonin Receptor Antagonists
      2. NK1 Receptor Antagonists
  6. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET, BY DRUG
    1. Segment Share
    2. Drug
      1. Existing Drugs
        1. Akynzeo (Netupitant-Palonosetron FDC)
        2. Aloxi (Palonosetron)
        3. Emend (Aprepitant)
        4. Kytril Generic (Granisetron)
        5. Zofran Generic (Ondansetron)
      2. Pipeline Drugs
        1. SUSTOL (Granisetron Injection extended release)
        2. Rolapitant
  7. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Therapy
      3. By Drug
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Therapy
      3. By Drug
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Therapy
      3. By Drug
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Therapy
      3. By Drug
  8. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. GlaxoSmithKline plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Tesaro, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Helsinn Group
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Heron Therapeutics, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Dr. Reddy's Laboratories Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Acacia Pharma
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Sun Pharmaceutical Industry Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Otsuka Holdings Co., Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX 
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us